Insider Transactions in Q1 2021 at Annexon, Inc. (ANNX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
Douglas Love PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
7,102
-100.0%
|
$198,856
$28.11 P/Share
|
|
Mar 31
2021
|
Douglas Love PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,102
+50.0%
|
$7,102
$1.41 P/Share
|
|
Mar 30
2021
|
Douglas Love PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
3,750
-75.33%
|
$90,000
$24.53 P/Share
|
|
Mar 30
2021
|
Douglas Love PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+50.0%
|
$3,750
$1.41 P/Share
|
|
Mar 29
2021
|
Douglas Love PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
3,750
-80.89%
|
$97,500
$26.23 P/Share
|
|
Mar 29
2021
|
Douglas Love PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+50.0%
|
$3,750
$1.41 P/Share
|
|
Mar 25
2021
|
Ted Yednock EVP & CHIEF INNOVATION OFFICER |
SELL
Open market or private sale
|
Direct |
16,175
-86.47%
|
$469,075
$29.24 P/Share
|
|
Mar 25
2021
|
Ted Yednock EVP & CHIEF INNOVATION OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
16,175
+28.39%
|
$48,525
$3.26 P/Share
|
|
Mar 24
2021
|
Sanjay Keswani EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,995
-100.0%
|
$119,850
$30.17 P/Share
|
|
Mar 24
2021
|
Sanjay Keswani EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,995
+50.0%
|
$27,965
$7.49 P/Share
|
|
Mar 23
2021
|
Jennifer Lew EVP & CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-33.17%
|
$140,000
$28.37 P/Share
|
|
Mar 23
2021
|
Jennifer Lew EVP & CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+41.67%
|
$35,000
$7.49 P/Share
|